The Latest Cardiac and Vascular News
SNOQUALMIE, Wash.–(BUSINESS WIRE)–Spacelabs Healthcare (the “Company” or “Spacelabs”), a division of OSI Systems, Inc. (“OSI Systems”) (NASDAQ: OSIS), today announced the release of Lifescreen™ Pro event screening system. Lifescreen Pro expands the Company’s non-invasive cardiology offerings, which include Spacelabs Pathfinder SL ambulatory ECG analysis system. Building on 40 years of technology, design, […]
– Treatment with sotatercept in the ongoing SPECTRA Phase 2 trial was associated with improvements in resting and exercise hemodynamics at week 24 – – Sotatercept was generally well tolerated, consistent with the previously reported safety profile in PAH and in other diseases – – Company-hosted investor and analyst conference […]
New health tech company to compete with consumer tech giants Apple and Fitbit IRVINE, Calif., May 17, 2021 /PRNewswire/ — CardieX Limited (ASX: CDX), a global health technology company focused on hypertension, cardiovascular disease, and vascular health disorders, today announced CONNEQT™, a new consumer health company that will focus on home vital signs monitors, […]
Clinically meaningful and statistically significant reduction of 16.6 mmHg in systolic blood pressure out to two years 88% of the treated patients had isolated systolic hypertension (ISH) 70.6% of all treated patients and 80% of treated ISH patients had their blood pressure under control at 24 months NEW HOPE, Pa., […]
BRADENTON, Fla.–(BUSINESS WIRE)–PaceMate™, the leading digital technology company in healthcare data management, is pleased to announce the appointment of seven cardiac electrophysiologist professionals as members of the company’s medical advisory board. As PaceMate™ continues forward in its mission to advance efficient digital healthcare solutions through innovative technology and its compassion-driven […]
Expanded and Product Portfolio Strengthens Offering in Access and Therapy Guidance CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced CE Mark Approval for a broad suite of […]
SAN CARLOS, Calif., May 12, 2021 /PRNewswire/ — Galaxy Medical (Galaxy) and Japan Lifeline (JLL) today announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the United States, developed by Japan Lifeline for use with the Galaxy CENTAURI™ Pulsed Electric Field (PEF) System. Under the terms of the agreement, Galaxy will pursue US […]
Peer-reviewed publication in the Journal of the American Heart Association found the AI algorithm detects clinically significant murmurs comparable to expert cardiologists OAKLAND, Calif., May 10, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced the peer-reviewed publication of a clinical study that found that the Eko artificial intelligence (AI) […]
– A new, first-of-its-kind study known as TAP-CHF leverages expertise across Abbott’s cardiovascular portfolio to optimize treatment for patients suffering from both AFib and heart failure – The trial will utilize Abbott technology including cardiac ablation and sensors to monitor for both pulmonary artery pressure and abnormal heartbeats – Historically, […]
Company Earns “Best Hospital Technology Implementation” Recognition for System-Wide Expansion of Rhythm CI Remote Telemetry ST. LOUIS, May 6, 2021 /PRNewswire/ — Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, announced that the company has been recognized by MedTech Breakthrough for the second consecutive year. The company earned recognition for the “Best Hospital […]
